Complex chromosomal rearrangement syndrome

Complex chromosomal rearrangement (CCR) syndrome refers to a group of structural chromosomal abnormalities involving three or more chromosomes or having more than two breakpoints. These rearrangements can include combinations of translocations, inversions, deletions, duplications, and insertions affecting multiple chromosomes simultaneously. Because the specific chromosomal regions involved vary widely from patient to patient, the clinical presentation is highly heterogeneous. CCRs can lead to genomic imbalances (gains or losses of chromosomal material) at the breakpoints or within rearranged segments, which are the primary drivers of clinical symptoms. The body systems affected depend entirely on which genes and chromosomal regions are disrupted. Common clinical features may include intellectual disability, developmental delay, congenital malformations (such as cardiac defects, craniofacial anomalies, and skeletal abnormalities), growth retardation, and reproductive problems including infertility and recurrent miscarriages. Some carriers of balanced CCRs may be phenotypically normal but face significant reproductive risks, as meiotic segregation errors can produce unbalanced gametes leading to offspring with chromosomal imbalances or pregnancy loss. Diagnosis is established through cytogenetic analysis, including conventional karyotyping, fluorescence in situ hybridization (FISH), and increasingly through chromosomal microarray analysis and whole-genome sequencing, which can detect cryptic imbalances at breakpoints. There is no specific curative treatment for CCR syndrome. Management is supportive and symptom-based, tailored to the individual's specific clinical manifestations. This may include early intervention programs, physical and occupational therapy, surgical correction of congenital anomalies, and genetic counseling for affected individuals and their families regarding recurrence risks.

Common questions about Complex chromosomal rearrangement syndrome